Cwa Asset Management Group, LLC Akebia Therapeutics, Inc. Transaction History
Cwa Asset Management Group, LLC
- $2.27 Billion
- Q2 2025
A detailed history of Cwa Asset Management Group, LLC transactions in Akebia Therapeutics, Inc. stock. As of the latest transaction made, Cwa Asset Management Group, LLC holds 57,000 shares of AKBA stock, worth $161,880. This represents 0.01% of its overall portfolio holdings.
Number of Shares
57,000
Previous 49,000
16.33%
Holding current value
$161,880
Previous $94,000
120.21%
% of portfolio
0.01%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding AKBA
# of Institutions
169Shares Held
105MCall Options Held
134KPut Options Held
262K-
Vanguard Group Inc Valley Forge, PA14.6MShares$41.5 Million0.0% of portfolio
-
Black Rock Inc. New York, NY11.6MShares$33.1 Million0.0% of portfolio
-
State Street Corp Boston, MA8MShares$22.7 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA6.07MShares$17.3 Million0.0% of portfolio
-
Satter Management Co., L.P.5.75MShares$16.3 Million20.26% of portfolio
About Akebia Therapeutics, Inc.
- Ticker AKBA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 183,848,992
- Market Cap $522M
- Description
- Akebia Therapeutics, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics for patients with kidney diseases. The company's lead product investigational product candidate is vadadustat, an oral therapy, which is in Phase III development for the treatment of anemia due to chronic kidney disease (CKD) ...